187 related articles for article (PubMed ID: 10781388)
21. Targeting population entering phase III trials: a new stratified adaptive phase II design.
Tournoux-Facon C; De Rycke Y; Tubert-Bitter P
Stat Med; 2011 Apr; 30(8):801-11. PubMed ID: 21432875
[TBL] [Abstract][Full Text] [Related]
22. On group sequential designs comparing two binomial proportions.
Kepner JL
J Biopharm Stat; 2010 Jan; 20(1):145-59. PubMed ID: 20077254
[TBL] [Abstract][Full Text] [Related]
23. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
Lachin JM
Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
[TBL] [Abstract][Full Text] [Related]
24. A composite design for transition from a preliminary to a full-scale study.
Lachin JM; Younes N
Stat Med; 2007 Nov; 26(27):5014-32. PubMed ID: 17577245
[TBL] [Abstract][Full Text] [Related]
25. Interim futility analysis with intermediate endpoints.
Goldman B; LeBlanc M; Crowley J
Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
[TBL] [Abstract][Full Text] [Related]
26. Monitoring rare serious adverse events from a new treatment and testing for a difference from historical controls.
Fay MP; Huang CY; Twum-Danso NA
Clin Trials; 2007; 4(6):598-610. PubMed ID: 18042569
[TBL] [Abstract][Full Text] [Related]
27. Stopping boundaries adjusted for sample size reestimation and negative stop.
Shun Z
J Biopharm Stat; 2002 Nov; 12(4):485-502. PubMed ID: 12477071
[TBL] [Abstract][Full Text] [Related]
28. Comparison of one-sample two-sided sequential t-tests for application in epidemiological studies.
van der Tweel I; Kaaks R; van Noord PA
Stat Med; 1996 Dec; 15(24):2781-95. PubMed ID: 8981686
[TBL] [Abstract][Full Text] [Related]
29. Group sequential t-test for clinical trials with small sample sizes across stages.
Shao J; Feng H
Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
[TBL] [Abstract][Full Text] [Related]
30. Stopping clinical trials early for benefit: impact on estimation.
Freidlin B; Korn EL
Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
[TBL] [Abstract][Full Text] [Related]
31. Sample size determination for comparing several survival curves with unequal allocations.
Halabi S; Singh B
Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
[TBL] [Abstract][Full Text] [Related]
32. Sequential analysis of latent variables using mixed-effect latent variable models: Impact of non-informative and informative missing data.
Sébille V; Hardouin JB; Mesbah M
Stat Med; 2007 Nov; 26(27):4889-904. PubMed ID: 17576119
[TBL] [Abstract][Full Text] [Related]
33. Conditional power calculations for clinical trials with historical controls.
Korn EL; Freidlin B
Stat Med; 2006 Sep; 25(17):2922-31. PubMed ID: 16479548
[TBL] [Abstract][Full Text] [Related]
34. Phase II multi-step planning methods in oncology: comparison, recommendations and potential applications.
Medioni J; de Rycke Y; Tournoux Facon C; Mallet A; Asselain B
Contemp Clin Trials; 2007 May; 28(3):249-57. PubMed ID: 17113357
[TBL] [Abstract][Full Text] [Related]
35. Sequential designs for clinical trials in amyotrophic lateral sclerosis.
Groeneveld GJ; van der Tweel I; Wokke JH; van den Berg LH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):202-7. PubMed ID: 15799547
[TBL] [Abstract][Full Text] [Related]
36. Optimal continuous sequential boundaries for monitoring toxicity in clinical trials: a restricted search algorithm.
Goldman AI; Hannan PJ
Stat Med; 2001 Jun; 20(11):1575-89. PubMed ID: 11391689
[TBL] [Abstract][Full Text] [Related]
37. A note on P-values under group sequential testing and nonproportional hazards.
Gillen DL; Emerson SS
Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
[TBL] [Abstract][Full Text] [Related]
38. Efficient group sequential designs when there are several effect sizes under consideration.
Jennison C; Turnbull BW
Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
[TBL] [Abstract][Full Text] [Related]
39. Adaptive designs for confirmatory clinical trials.
Bretz F; Koenig F; Brannath W; Glimm E; Posch M
Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
[TBL] [Abstract][Full Text] [Related]
40. Over-ruling a group sequential boundary--a stopping rule versus a guideline.
Lan KK; Lachin JM; Bautista O
Stat Med; 2003 Nov; 22(21):3347-55. PubMed ID: 14566919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
